Landec Corporation Sets Second Quarter 2021 Earnings Conference Call for January 6, 2021 at 2 p.m. PT
December 22 2020 - 8:00AM
Landec Corporation (Nasdaq: LNDC), a diversified health and
wellness company with two operating businesses, Curation Foods,
Inc. and Lifecore Biomedical, Inc., will hold a conference call on
Wednesday, January 6, 2021 at 2 p.m. Pacific time to discuss its
results for the fiscal second quarter 2021. Financial results will
be reported for the 2021 fiscal second quarter ended November 29,
2020 after market close on January 6, 2021.
Landec's President and CEO, Dr. Albert Bolles,
will host the Conference Call with Brian McLaughlin, Chief
Financial Officer and Jim Hall, Lifecore President. A question and
answer period will follow the presentation.
Date: Wednesday, January 6, 2021 Time: 2 p.m.
Pacific time (5 p.m. Eastern time) Toll Free Participant Dial-in
Number: 1-877-407-3982 U.S. and International Toll Number:
1-201-493-6780 Conference ID: 13714051 Webcast:
http://ir.Landec.com/events.cfm The webcast will be available for
30 days through February 6, 2021.
A replay of the teleconference will be available
for one week until midnight Eastern Time on Wednesday, January 13,
2021.
Toll free replay dial in: 1-844-512-2921
International replay: 1-412-317-6671 Replay passcode: 13714051
About Landec Corporation Landec
Corporation (NASDAQ: LNDC) is a leading innovator of diversified
health and wellness solutions with two operating businesses:
Curation Foods, Inc. and Lifecore Biomedical, Inc. Landec designs,
develops, manufactures, and sells products for the food and
biopharmaceutical industry. Curation Foods is focused on innovating
and distributing plant-based foods with 100% clean ingredients to
retail, club and foodservice channels throughout North America.
Curation Foods is able to maximize product freshness through its
geographically dispersed family of growers, refrigerated supply
chain and patented BreatheWay® packaging technology. Curation
Foods brands include Eat Smart® fresh packaged vegetables and
salads, O Olive Oil & Vinegar® premium artisan products,
and Yucatan® and Cabo Fresh® avocado products. Lifecore
Biomedical is a fully integrated contract development and
manufacturing organization (CDMO) that offers highly differentiated
capabilities in the development, fill and finish of sterile,
injectable pharmaceutical products in syringes and vials. As a
leading manufacturer of premium, injectable grade Hyaluronic Acid,
Lifecore brings 35 years of expertise as a partner for global and
emerging biopharmaceutical and biotechnology companies across
multiple therapeutic categories to bring their innovations to
market. For more information about the Company, visit Landec’s
website at www.landec.com.
Contact Information:
Investor Relations:Jeff
Sonnek(646) 277-1263jeff.sonnek@icrinc.com
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Apr 2023 to Apr 2024